Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption

Journal of the Acoustical Society of America

Volumn 126, Issue 6, 2009, Pages 3344-3349

  Yang, Feng Yi ^a,b   Liu, Shing Hwa ^c   Ho, Feng Ming ^d   Chang, Chi Hong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC POWER; ACOUSTICAL POWER; BLOOD-BRAIN BARRIER; DUTY CYCLES; EVANS BLUE; FEMORAL VEIN; FOCUSED ULTRASOUND; FUNCTION OF TIME; REPETITION FREQUENCY; SPRAGUE-DAWLEY RATS; TARGET REGIONS; ULTRASOUND CONTRAST AGENT; ULTRASOUND FREQUENCY;

ACOUSTIC WAVES; BLOOD; RATS; SONICATION; ULTRASONICS;

ULTRASONIC IMAGING;

ECHO CONTRAST MEDIUM; EVANS BLUE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CONTROLLED STUDY; EXTRAVASATION; FEMORAL VEIN; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPRAGUE DAWLEY RAT; ULTRASOUND;

ACOUSTICS; ANIMALS; BLOOD VESSELS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EVANS BLUE; MAGNETIC RESONANCE IMAGING; MALE; RATS; TIME FACTORS; ULTRASONICS;

EID: 72549092448     PISSN: 00014966     EISSN: None     Source Type: Journal    
DOI: 10.1121/1.3242376     Document Type: Article

References (24)

1. L. L. Rubin and J. M. Staddon, " The cell biology of the blood-brain barrier.," Annu. Rev. Neurosci. 22, 11-28 (1999). 10.1146/annurev.neuro. 22.1.11 (Pubitemid 29144879)
2. R. A. Kroll and E. A. Neuwelt, " Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.," Neurosurgery 42, 1083-1099 (1998). 10.1097/00006123-199805000-00082 (Pubitemid 28196521)
3. M. Kinoshita, N. McDannold, F. A. Jolesz, and K. Hynynen, " Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.," Proc. Natl. Acad. Sci. U.S.A. 103, 11719-11723 (2006). 10.1073/pnas.0604318103 (Pubitemid 44182517)
4. W. M. Pardridge, " Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.," Curr. Opin. Drug Discovery Dev. 6, 683-691 (2003).
5. W. M. Pardridge, " Drug and gene delivery to the brain: The vascular route.," Neuron 36, 555-558 (2002). 10.1016/S0896-6273(02)01054-1 (Pubitemid 35346750)
6. W. M. Pardridge, " Drug and gene targeting to the brain with molecular Trojan horses.," Nat. Rev. Drug Discovery 1, 131-139 (2002). 10.1038/nrd725 (Pubitemid 41646520)
7. K. Hynynen, N. McDannold, N. A. Shcikov, F. A. Jolesz, and N. Vykhodtseva, " Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.," Neuroimage 24, 12-20 (2005). 10.1016/j.neuroimage.2004.06. 046 (Pubitemid 39611021)
8. J. J. Choi, M. Pernot, T. R. Brown, S. A. Small, and E. E. Konofagou, " Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound.," Phys. Med. Biol. 52, 5509-5530 (2007). 10.1088/0031-9155/52/18/004 (Pubitemid 350056681)
9. N. McDannold, N. Vykhodtseva, and K. Hynynen, " Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption.," Ultrasound Med. Biol. 34, 930-937 (2008). 10.1016/j.ultrasmedbio.2007.11.009 (Pubitemid 351697595)
10. K. Hynynen, N. McDannold, N. Vykhodtseva, and F. A. Jolesz, " Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits.," Radiology 220, 640-646 (2001). 10.1148/radiol.2202001804
11. S. B. Raymond, J. Skoch, K. Hynynen, and B. J. Bacskai, " Multiphoton imaging of ultrasound/optison mediated cerebrovascular effects in vivo.," J. Cereb. Blood Flow Metab. 27, 393-403 (2007). 10.1038/sj.jcbfm.9600336 (Pubitemid 46148465)
12. S. B. Raymond, L. H. Treat, J. D. Dewey, N. J. McDannold, K. Hynynen, and B. J. Bacskai, " Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models.," PLoS ONE 3, e2175 (2008). 10.1371/journal.pone.0002175
13. A. H. Mesiwala, L. Farrell, H. J. Wenzel, D. L. Silbergeld, L. A. Crum, H. R. Winn, and P. D. Mourad, " High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo.," Ultrasound Med. Biol. 28, 389-400 (2002). 10.1016/S0301-5629(01)00521-X (Pubitemid 34308920)
14. F. Y. Yang, W. M. Fu, W. S. Chen, W. L. Yeh, and W. L. Lin, " Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption.," Ultrason. Sonochem. 15, 636-643 (2008). 10.1016/j.ultsonch.2007.08.003 (Pubitemid 351726275)
15. F. Y. Yang, W. M. Fu, R. S. Yang, H. C. Liou, K. H. Kang, and W. L. Lin, " Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption.," Ultrasound Med. Biol. 33, 1421-1427 (2007). 10.1016/j.ultrasmedbio.2007.04.006 (Pubitemid 47302206)
16. H. S. Sharma and P. K. Dey, " Influence of long-term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats.," J. Neurol. Sci. 72, 61-76 (1986). 10.1016/0022-510X(86)90036-5 (Pubitemid 16206328)
17. D. L. Miller, " Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation.," Prog. Biophys. Mol. Biol. 93, 314-330 (2007). 10.1016/j.pbiomolbio.2006.07.027 (Pubitemid 44809394)
18. K. Hynynen, N. McDannold, N. Vykhodtseva, S. Raymond, R. Weissleder, F. A. Jolesz, and N. Sheikov, " Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: A method for molecular imaging and targeted drug delivery.," J. Neurosurg. 105, 445-454 (2006). 10.3171/jns.2006.105.3. 445
19. N. Sheikov, N. McDannold, N. Vykhodtseva, F. Jolesz, and K. Hynynen, " Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles.," Ultrasound Med. Biol. 30, 979-989 (2004). 10.1016/j.ultrasmedbio.2004.04.010 (Pubitemid 39094314)
20. K. Hynynen, " Ultrasound for drug and gene delivery to the brain.," Adv. Drug Delivery Rev. 60, 1209-1217 (2008). 10.1016/j.addr.2008. 03.010
21. N. Vykhodtseva, N. McDannold, and K. Hynynen, " Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.," Ultrasonics 48, 279-296 (2008). 10.1016/j.ultras.2008.04.004
22. L. H. Treat, N. McDannold, N. Vykhodtseva, Y. Zhang, K. Tam, and K. Hynynen, " Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound.," Int. J. Cancer 121, 901-907 (2007). 10.1002/ijc.22732
23. F. Fazekas, R. Kleinert, G. Roob, G. Kleinert, P. Kapeller, R. Schmidt, and H. P. Hartung, " Histopathologic analysis of foci of signal loss on gradient-echo T 2* -weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.," AJNR Am. J. Neuroradiol. 20, 637-642 (1999).
24. V. Sehgal, Z. Delproposto, D. Haddar, E. M. Haacke, A. E. Sloan, L. J. Zamorano, G. Barger, J. Hu, Y. Xu, K. P. Prabhakaran, I. R. Elangovan, J. Neelavalli, and J. R. Reichenbach, " Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.," J. Magn. Reson Imaging 24, 41-51 (2006). 10.1002/jmri.20598